Skip to main content
Clinical Trials/NCT06318624
NCT06318624
Completed
Not Applicable

Immediate Effects of Ankle Mobilization With Movement and Mulligan Talocrural Taping on Gait and Balance in Stroke Patients

Kutahya Health Sciences University1 site in 1 country52 target enrollmentFebruary 14, 2024
ConditionsStroke

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Stroke
Sponsor
Kutahya Health Sciences University
Enrollment
52
Locations
1
Primary Endpoint
The symmetry of the center of pressure changes during walking
Status
Completed
Last Updated
last year

Overview

Brief Summary

Disorders caused by stroke may lead to significant limitations, especially in ankle range of motion, and may cause impairments in walking and balance functions. This limitation in ankle range of motion leads to difficulties in weight transfer, stability, and balance. As a result, there is a decrease in walking performance and an increased risk of falls. Various interventions have been used to improve ankle dorsiflexion passive range of motion, including gastrosoleus muscle stretching, muscle strengthening training, functional electrical stimulation training, proprioceptive control training, taping, manual therapy, different mobilization techniques, and ankle mobilization with motion (MWM).There are limited studies investigating the immediate effects of MWM and taping on gait and balance in stroke patients. This study was planned to investigate the effect of Mulligan's ankle MWM technique and talus stabilization taping on spatiotemporal gait and balance parameters in stroke patients.

Registry
clinicaltrials.gov
Start Date
February 14, 2024
End Date
October 11, 2024
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Kutahya Health Sciences University
Responsible Party
Principal Investigator
Principal Investigator

Ismail Okur

Asst. Prof.

Kutahya Health Sciences University

Eligibility Criteria

Inclusion Criteria

  • Having a unilateral stroke for more than three months,
  • Being able to walk 10 meters without an assistive device,
  • Being able to walk unassisted before having a stroke,
  • Having a score of 3 or lower on the Modified Ashworth Scale (MAS),
  • Be able to follow simple verbal instructions,
  • Being Volunteer

Exclusion Criteria

  • Having had more than one stroke,
  • Cerebellar involvement,
  • Having severe visual impairment,
  • Having cognitive impairment,
  • Severe aphasia,
  • Having contraindications for joint mobilization (e.g. ankle hypermobility, trauma, inflammation),
  • Have significant lower limb problems such as fractures or arthritis,
  • Having undergone musculoskeletal surgery less than 6 months ago,
  • Having joint contracture in the paretic ankle that prevents walking.

Outcomes

Primary Outcomes

The symmetry of the center of pressure changes during walking

Time Frame: Pre-intervention/sham and immediately after the intervention/sham

Spatiotemporal parameters of gait will be evaluated with the Zebris FDM-2 device. The symmetry of the center of pressure changes during walking spatiotemporal parameters of gait will be obtained from this platform. The date will recorded as a millimeter.

Cadance

Time Frame: Pre-intervention/sham and immediately after the intervention/sham

Spatiotemporal parameters of gait will be evaluated with the Zebris FDM-2 device. Cadance spatiotemporal parameters of gait will be obtained from this platform. The date will recorded as the number of steps per minute.

The distribution of pressure on the feet

Time Frame: Pre-intervention/sham and immediately after the intervention/sham

Spatiotemporal parameters of gait will be evaluated with the Zebris FDM-2 device. The distribution of pressure on the feet spatiotemporal parameters of gait will be obtained from this platform. The date will recorded as percentages.

Balance

Time Frame: Pre-intervention/sham and immediately after the intervention/sham

Zebris FDM-2 device will also be used for the evaluation of balance parameters. Participants will be asked to stand on the device for 60 seconds without shoes, arms at their sides, eyes open and looking at a point 3 meters away. As a result of the evaluation, changes in the center of pressure will be recorded.

Walking speed

Time Frame: Pre-intervention/sham and immediately after the intervention/sham

Spatiotemporal parameters of gait will be evaluated with the Zebris FDM-2 device. Walking speed spatiotemporal parameters of gait will be obtained from this platform. The date will recorded as m/s.

The maximum force on the feet during walking

Time Frame: Pre-intervention/sham and immediately after the intervention/sham

Spatiotemporal parameters of gait will be evaluated with the Zebris FDM-2 device. The maximum force on the feet during walking spatiotemporal parameters of gait will be obtained from this platform. The date will recorded as N/cm2.

Stride length

Time Frame: Pre-intervention/sham and immediately after the intervention/sham

Spatiotemporal parameters of gait will be evaluated with the Zebris FDM-2 device. Stride length spatiotemporal parameters of gait will be obtained from this platform. The date will recorded as a millimeter.

Stride width

Time Frame: Pre-intervention/sham and immediately after the intervention/sham

Spatiotemporal parameters of gait will be evaluated with the Zebris FDM-2 device. Stride width spatiotemporal parameters of gait will be obtained from this platform. The date will recorded as a millimeter.

Secondary Outcomes

  • Timed up and go test(Pre-intervention/sham and immediately after the intervention/sham)
  • 10-meter walk test(Pre-intervention/sham and immediately after the intervention/sham)

Study Sites (1)

Loading locations...

Similar Trials